1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Finland Pharmaceuticals and Healthcare Report Q1 2016

Finland Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 70 pages

Includes 3 FREE quarterly updates

BMI View: In light of Finland's bleak economic outlook, we expect the government to remain focused onausterity measures that target the healthcare sector Finland's ageing population will drive demand forexpensive innovative medicines, which will add additional pressure on the government to implement furtherprice cuts on drugs As a result, the market will become increasingly challenging for innovativedrugmakers, impacting company revenues over the long term

Headline Expenditure Projections

- Pharmaceuticals: EUR285bn (USD382bn) in 2014 to EUR293bn (USD323bn) in 2015;+30% inlocal currency terms and -154% in US dollar terms Forecast unchanged from last quarter
- Healthcare: EUR1888bn (USD2530bn) in 2014 to EUR1963bn (USD2159bn) in 2015; +40% in localcurrency terms and -147% in US dollar terms Forecast unchanged from last quarter

Table Of Contents

Finland Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Finland 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Finland 2011-2019) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2011-2019) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2011-2019) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2011-2019) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Finland 2011-2019) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Finland 2011-2019) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Finland 2011-2019) 22
OTC Medicine Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Finland 2011-2019) 24
Pharmaceutical Trade Forecast 25
Table: Pharmaceutical Trade Data And Forecasts (Finland 2013-2019) 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Finland 2013-2019) 26
Industry Risk/Reward Index 27
Western Europe Risk/Reward Index 27
Finland Risk/Reward Index 33
Rewards 33
Risks 33
Regulatory Review 35
Pricing and Reimbursement 37
Intellectual Property 41
Market Overview 43
Epidemiology 44
Health Insurance 47
Table: Healthcare Resources (Finland 2009-2014) 50
Table: Healthcare Personnel (Finland 2009-2014) 50
Table: Healthcare Activity (Finland 2009-2014) 51
Research and Development 51
Clinical Trials 52
Competitive Landscape 54
Table: Multinational Market Activity 54
Table: PIF Members 57
Company Developments 57
Demographic Forecast 59
Table: Population Headline Indicators (Finland 1990-2025) 60
Table: Key Population Ratios (Finland 1990-2025) 60
Table: Urban/Rural Population and Life Expectancy (Finland 1990-2025) 61
Table: Population By Age Group (Finland 1990-2025) 61
Table: Population By Age Group % (Finland 1990-2025) 62
Glossary 64
Methodology 66
Pharmaceutical Expenditure Forecast Model 66
Healthcare Expenditure Forecast Model 66
Notes On Methodology 67
Risk/Reward Index Methodology 68
Index Overview 69
Table: Pharmaceutical Risk/Reward Index Indicators 69
Indicator Weightings 70

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.